BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 22, 2013
View Archived Issues
Proteologics and Newcastle Innovation enter exclusive agreement
Read More
GPBB as a novel plasma biomarker for ischemic stroke
Read More
Japanese MHLW approves use of triple therapy with proton pump inhibitors for new indication
Read More
AT2 receptor agonist prevents ischemic brain damage after stroke
Read More
Gemzar approved for recurrent or refractory malignant lymphoma in Japan
Read More
New ERK inhibitors patented by Array BioPharma and Genentech
Read More
IMPACT Therapeutics presents new hedgehog inhibitors
Read More
Chinese group divulges new protein kinase inhibitors for cancer
Read More
Canadian university researchers synthesize novel inhibitors of ABHD6
Read More
New tyrosine-protein kinase inhibitors designed by Chinese researchers
Read More
Eisai transfers U.S. rights to Targretin
Read More
Adasuve receives European marketing authorization
Read More
First patient treated in G-202 phase II trial
Read More
FDA recommends phase III Androxal studies to be completed as planned
Read More
Phase III trial of Lyrica for partial onset seizures meets primary endpoint
Read More
Relypsa enrolls first patient in pivotal phase III patiromer trial
Read More
UCB and ConfometRx form multitarget R&D partnership
Read More
Organovo and ZenBio to create living 3D tissue models
Read More
PLX cells given FDA orphan drug status for aplastic anemia
Read More
Efficacy of velaglucerase alfa treatment evaluated over 7 years
Read More
Otsuka set to launch Neupro Patch in Japan
Read More
Genz-682452 shows potential as adjuvant therapy for Fabry disease
Read More
Janssen submits application for approval of simeprevir in Japan
Read More
New formulation of Afinitor now available in Japan
Read More
GlaxoSmithKline launches antimalarial combination tablet in Japan
Read More
CCL23 as a novel blood biomarker of brain damage
Read More
Alfresa Pharma launches Choreazine in Japan
Read More